Linking system-wide impacts of RNA polymerase mutations to the fitness cost of rifampin resistance in Pseudomonas aeruginosa

mBio

Volumn 5, Issue 6, 2014, Pages

  Qi, Qin ^a   Preston, Gail M ^a   Maclean, R Craig ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

RIFAMPICIN; RNA POLYMERASE BETA SUBUNIT; ANTIINFECTIVE AGENT; DNA DIRECTED RNA POLYMERASE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; ENZYME ACTIVITY; ESSENTIAL GENE; GENE EXPRESSION; GENE MUTATION; GENE REGULATORY NETWORK; GENETIC TRANSCRIPTION; NONHUMAN; OPERON; PLEIOTROPY; PSEUDOMONAS AERUGINOSA; RNA SEQUENCE; RPOB GENE; UPREGULATION; DRUG EFFECTS; ENZYMOLOGY; GENE EXPRESSION PROFILING; GENETICS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; MUTATION;

PSEUDOMONAS AERUGINOSA;

ANTI-BACTERIAL AGENTS; DNA-DIRECTED RNA POLYMERASES; DRUG RESISTANCE, BACTERIAL; GENE EXPRESSION PROFILING; GENES, ESSENTIAL; MUTATION; PSEUDOMONAS AERUGINOSA; RIFAMPIN; TRANSCRIPTION, GENETIC;

EID: 84920903379     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.01562-14     Document Type: Article

References (55)

1. Andersson DI, Hughes D. 2010. Antibiotic resistance and its cost: is it possible to reverse resistance? Nat. Rev. Microbiol. 8:260-271. http://dx.doi.org/10.1038/nrmicro2319.
2. Andersson DI. 2006. The biological cost of mutational antibiotic resistance: any practical conclusions? Curr. Opin. Microbiol. 9:461-465. http://dx.doi.org/10.1016/j.mib.2006.07.002.
3. MacLean RC, Hall AR, Perron GG, Buckling A. 2010. The population genetics of antibiotic resistance: integrating molecular mechanisms and treatment contexts. Nat. Rev. Genet. 11:405-414. http://dx.doi.org/10.1038/nrg2778.
4. Vogwill T, MacLean RC. The genetic basis of the fitness costs of antimicrobial resistance: a meta-analysis approach. Evol. Appl., in press.
5. Sandegren L, Lindqvist A, Kahlmeter G, Andersson DI. 2008. Nitrofurantoin resistance mechanism and fitness cost in Escherichia coli. J. Antimicrob. Chemother. 62:495-503. http://dx.doi.org/10.1093/jac/dkn222.
6. Binet R, Maurelli AT. 2007. Frequency of development and associated physiological cost of azithromycin resistance in Chlamydia psittaci 6BC and C. trachomatis L2. Antimicrob. Agents Chemother. 51:4267-4275. http://dx.doi.org/10.1128/AAC.00962-07.
7. Besier S, Ludwig A, Zander J, Brade V, Wichelhaus TA. 2008. Linezolid resistance in Staphylococcus aureus: gene dosage effect, stability, fitness costs, and cross-resistances. Antimicrob. Agents Chemother. 52: 1570-1572. http://dx.doi.org/10.1128/AAC.01098-07.
8. Paulander W, Maisnier-Patin S, Andersson DI. 2009. The fitness cost of streptomycin resistance depends on rpsL mutation, carbon source and RpoS (sigmaS). Genetics 183:539-546. http://dx.doi.org/10.1534/genetics.109.106104.
9. Hall AR, Iles JC, MacLean RC. 2011. The fitness cost of rifampicin resistance in Pseudomonas aeruginosa depends on demand for RNA polymerase. Genetics 187:817-822. http://dx.doi.org/10.1534/genetics.110.124628.
10. Macvanin M, Johanson U, Ehrenberg M, Hughes D. 2000. Fusidic acid-resistant EF-G perturbs the accumulation of ppGpp. Mol. Microbiol. 37:98-107. http://dx.doi.org/10.1046/j.1365-2958.2000.01967.x.
11. Zorzet A, Pavlov MY, Nilsson AI, Ehrenberg M, Andersson DI. 2010. Error-prone initiation factor 2 mutations reduce the fitness cost of antibiotic resistance. Mol. Microbiol. 75:1299-1313. http://dx.doi.org/10.1111/j.1365-2958.2010.07057.x.
12. Wehrli W. 1983. Rifampin: mechanisms of action and resistance. Rev. Infect. Dis. 5(Suppl 3):S407-S411. http://dx.doi.org/10.1093/clinids/5.Supplement_3.S407.
13. Villain-Guillot P, Bastide L, Gualtieri M, Leonetti JP. 2007. Progress in targeting bacterial transcription. Drug Discov. Today 12:200-208. http://dx.doi.org/10.1016/j.drudis.2007.01.005.
14. Hartmann G, Honikel KO, Knüsel F, Nüesch J. 1967. The specific inhibition of the DNA-directed RNA synthesis by rifamycin. Biochim. Biophys. Acta 145:843-844. http://dx.doi.org/10.1016/0005-2787(67)90147-5.
15. Kessler C, Hartmann GR. 1977. The two effects of rifampicin on the RNA polymerase reaction. Biochem. Biophys. Res. Commun. 74:50-56. http://dx.doi.org/10.1016/0006-291X(77)91373-0.
16. Severinov K, Soushko M, Goldfarb A, Nikiforov V. 1993. Rifampicin region revisited. New rifampicin-resistant and streptolydigin-resistant mutants in the beta subunit of Escherichia coli RNA polymerase. J. Biol. Chem. 268:14820-14825.
17. Jin DJ, Gross CA. 1989. Characterization of the pleiotropic phenotypes of rifampin-resistant rpoB mutants of Escherichia coli. J. Bacteriol. 171: 5229-5231.
18. Gagneux S, Long CD, Small PM, Van T, Schoolnik GK, Bohannan BJ. 2006. The competitive cost of antibiotic resistance in Mycobacterium tuberculosis. Science 312:1944-1946. http://dx.doi.org/10.1126/science.1124410.
19. Wichelhaus TA, Böddinghaus B, Besier S, Schäfer V, Brade V, Ludwig A. 2002. Biological cost of rifampin resistance from the perspective of Staphylococcus aureus. Antimicrob. Agents Chemother. 46:3381-3385. http://dx.doi.org/10.1128/AAC.46.11.3381-3385.2002.
20. Brandis G, Wrande M, Liljas L, Hughes D. 2012. Fitness-compensatory mutations in rifampicin-resistant RNA polymerase. Mol. Microbiol. 85: 142-151. http://dx.doi.org/10.1111/j.1365-2958.2012.08099.x.
21. Reynolds MG. 2000. Compensatory evolution in rifampin-resistant Escherichia coli. Genetics 156:1471-1481.
22. Matsuo M, Hishinuma T, Katayama Y, Cui L, Kapi M, Hiramatsu K. 2011. Mutation ofRNApolymerase beta subunit (rpoB) promotes hVISAto-VISA phenotypic conversion of strain Mu3. Antimicrob. Agents Chemother. 55:4188-4195. http://dx.doi.org/10.1128/AAC.00398-11.
23. Hall AR. 2013. Genotype-by-environment interactions due to antibiotic resistance and adaptation in Escherichia coli. J. Evol. Biol. 26:1655-1664. http://dx.doi.org/10.1111/jeb.12172.
24. Perkins AE, Nicholson WL. 2008. Uncovering new metabolic capabilities of Bacillus subtilis using phenotype profiling of rifampin-resistant rpoB mutants. J. Bacteriol. 190:807-814. http://dx.doi.org/10.1128/JB.00901-07.
25. du Preez I, Loots DT. 2012. Altered fatty acid metabolism due to rifampicin-resistance conferring mutations in the rpoB gene of Mycobacterium tuberculosis: mapping the potential of pharmaco-metabolomics for global health and personalized medicine. OMICS 16:596-603. http://dx.doi.org/10.1089/omi.2012.0028.
26. Cooper TF, Ostrowski EA, Travisano M. 2007. A negative relationship between mutation pleiotropy and fitness effect in yeast. Evolution 61: 1495-1499. http://dx.doi.org/10.1111/j.1558-5646.2007.00109.x.
27. MacLean RC, Bell G, Rainey PB. 2004. The evolution of a pleiotropic fitness tradeoff in Pseudomonas fluorescens. Proc. Natl. Acad. Sci. U. S. A. 101:8072-8077. http://dx.doi.org/10.1073/pnas.0307195101.
28. Jordan IK, Rogozin IB, Wolf YI, Koonin EV. 2002. Essential genes are more evolutionarily conserved than are nonessential genes in bacteria. Genome Res. 12:962-968. http://dx.doi.org/10.1101/gr.87702.
29. Stewart GS, Williams P. 1992. lux genes and the applications of bacterial bioluminescence. J. Gen. Microbiol. 138:1289-1300. http://dx.doi.org/10.1099/00221287-138-7-1289.
30. Van Dyk TK, Rosson RA. 1998. Photorhabdus luminescens luxCDABE promoter probe vectors. Methods Mol. Biol. 102:85-95.
31. Brandis G, Hughes D. 2013. Genetic characterization of compensatory evolution in strains carrying rpoB Ser531Leu, the rifampicin resistance mutation most frequently found in clinical isolates. J. Antimicrob. Chemother. 68:2493-2497. http://dx.doi.org/10.1093/jac/dkt224.
32. Comas I, Borrell S, Roetzer A, Rose G, Malla B, Kato-Maeda M, Galagan J, Niemann S, Gagneux S. 2012. Whole-genome sequencing of rifampicin-resistant Mycobacterium tuberculosis strains identifies compensatory mutations in RNA polymerase genes. Nat. Genet. 44:106-110.
33. Krebs JE, Lewin B, Kilpatrick ST, Goldstein ES. 2013. Lewin’s genes, 11th ed. Jones & Bartlett Learning, Burlington, MA.
34. Silander OK, Nikolic N, Zaslaver A, Bren A, Kikoin I, Alon U, Ackermann M. 2012. A genome-wide analysis of promoter-mediated phenotypic noise in Escherichia coli. PLoS Genet. 8:e1002443. http://dx.doi.org/10.1371/journal.pgen.1002443.
35. Winsor GL, Lam DK, Fleming L, Lo R, Whiteside MD, Yu NY, Hancock RE, Brinkman FS. 2011. Pseudomonas Genome Database: improved comparative analysis and population genomics capability for Pseudomonas genomes. Nucleic Acids Res. 39:D596-D600. http://dx.doi.org/10.1093/nar/gkq869.
36. Heilbron K, Toll-Riera M, Kojadinovic M, Maclean RC. 2014. Fitness is strongly influenced by rare mutations of large effect in a microbial mutation accumulation experiment. Genetics 197:981-990. http://dx.doi.org/10.1534/genetics.114.163147.
37. Liberati NT, Urbach JM, Miyata S, Lee DG, Drenkard E, Wu G, Villanueva J, Wei T, Ausubel FM. 2006. An ordered, nonredundant library of Pseudomonas aeruginosa strain PA14 transposon insertion mutants. Proc. Natl. Acad. Sci. U. S. A. 103:2833-2838. http://dx.doi.org/10.1073/pnas.0511100103.
38. Bass IA, Danilevskaya ON, Mekhedov SL, Fedoseeva VB, Gorlenko ZM. 1979. The effect of rifampicin upon the transcription of RNA polymerase beta-gene in Escherichia coli. Mol. Gen. Genet. 173:101-107. http://dx.doi.org/10.1007/BF00267695.
39. Little R, Dennis PP. 1979. Expression of RNA polymerase and ribosome component genes in Escherichia coli mutants having conditionally defective RNA polymerases. J. Bacteriol. 137:115-123.
40. Blumenthal RM, Dennis PP. 1978. Gene expression in Escherichia coli B/r during partial rifampicin-mediated restrictions of transcription initiation. Mol. Gen. Genet. 165:79-86. http://dx.doi.org/10.1007/BF00270379.
41. Hayward RS, Fyfe SK. 1978. Non-coordinate expression of the neighbouring genes rplL and rpoB,C of Escherichia coli. Mol. Gen. Genet. 160: 77-80.
42. Morgan BA, Hayward RS. 1987. Direct evidence for rifampicinpromoted readthrough of the partial terminator tL7 in the rpoBC operon of Escherichia coli. Mol. Gen. Genet. 210:358-363. http://dx.doi.org/10.1007/BF00325706.
43. Jin DJ, Walter WA, Gross CA. 1988. Characterization of the termination phenotypes of rifampicin-resistant mutants. J. Mol. Biol. 202:245-253. http://dx.doi.org/10.1016/0022-2836(88)90455-X.
44. Choi KH, Schweizer HP. 2006. Mini-Tn7 insertion in bacteria with single attTn7 sites: example Pseudomonas aeruginosa. Nat. Protoc. 1:153-161. http://dx.doi.org/10.1038/nprot.2006.24.
45. Bao Y, Lies DP, Fu H, Roberts GP. 1991. An improved Tn7-based system for the single-copy insertion of cloned genes into chromosomes of gramnegative bacteria. Gene 109:167-168. http://dx.doi.org/10.1016/0378-1119(91)90604-A.
46. Luria SE, Delbrück M. 1943. Mutations of bacteria from virus sensitivity to virus resistance. Genetics 28:491-511.
47. MacLean RC, Buckling A. 2009. The distribution of fitness effects of beneficial mutations in Pseudomonas aeruginosa. PLoS Genet. 5:e1000406. http://dx.doi.org/10.1371/journal.pgen.1000406.
48. MacLean RC, Perron GG, Gardner A. 2010. Diminishing returns from beneficial mutations and pervasive epistasis shape the fitness landscape for rifampicin resistance in Pseudomonas aeruginosa. Genetics 186: 1345-1354. http://dx.doi.org/10.1534/genetics.110.123083.
49. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F. 2002. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 3:-research0034.11. http://dx.doi.org/10.1186/gb-2002-3-7-research0034.
50. Andersen CL, Jensen JL, Ørntoft TF. 2004. Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res. 64:5245-5250. http://dx.doi.org/10.1158/0008-5472.CAN-04-0496.
51. Trapnell C, Pachter L, Salzberg SL. 2009. TopHat: discovering splice junctions with RNA-Seq. Bioinformatics 25:1105-1111. http://dx.doi.org/10.1093/bioinformatics/btp120.
52. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J, Hornik K, Hothorn T, Huber W, Iacus S, Irizarry R, Leisch F, Li C, Maechler M, Rossini AJ, Sawitzki G, Smith C, Smyth G, Tierney L, Yang JY, Zhang J. 2004. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 5:R80. http://dx.doi.org/10.1186/gb-2004-5-10-r80.
53. Anders S, Huber W. 2010. Differential expression analysis for sequence count data. Genome Biol. 11:R106. http://dx.doi.org/10.1186/gb-2010-11-10-r106.
54. Anders S, McCarthy DJ, Chen Y, Okoniewski M, Smyth GK, Huber W, Robinson MD. 2013. Count-based differential expression analysis of RNA sequencing data using R and Bioconductor. Nat. Protoc. 8:1765-1786. http://dx.doi.org/10.1038/nprot.2013.099.
55. Benjamini Y, Hochberg Y. 1995. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. Series B Stat. Methodol. 85:289-300.